Global Radiofrequency Ablation Market 2017-2021

  • ID: 4202018
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 7

FEATURED COMPANIES

  • Accuray
  • AtriCure
  • Bovie Medical
  • Halyard Health
  • Medtronic
  • PLC Medical Systems
  • MORE
About Radiofrequency Ablation
Radiofrequency ablation devices are used to treat medical conditions such as cancer tumors with the help of imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound by using minimally invasive (MI) techniques. This involves the use of high-frequency electromagnetic waves to generate heat energy (alternating current). Radiofrequency ablation is used by surgeons to destroy cancerous cells, and remove or trim obstructive tissues and dead nerves. The process is carried out by inserting a special needle through the skin onto the tumor. The procedure targets specific tissue/nerve with radiofrequency electrical energy, heating the tumor through an active exposed electrode tip.

The analysts forecast the global radiofrequency ablation market to grow at a CAGR of 8.78% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global radiofrequency ablation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of equipment and accessories used in radiofrequency ablation.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Radiofrequency Ablation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- AngioDynamics
- Boston Scientific
- Medtronic
- St. Jude Medical
- Stryker

Other prominent vendors
- Accuray
- Advanced Cardiac Therapeutics
- APT Medical
- Arthrex
- AtriCure
- Biosense Webster
- BIOTRONIK
- Bovie Medical
- CardioFocus
- CONMED
- DVx
- Hansen Medical
- Halyard Health
- Imricor Medical Systems
- Japan Lifeline
- Merit Medical Systems
- MicroPort Scientific
- Osypka Medical
- PLC Medical Systems
- RF Medical
- Smith & Nephew
- Spacelabs Healthcare
- Spectranetics
- Theraclion
- Total Vein Systems

Market drivers
- Increasing incidence of chronic disorders and growing older population
- For a full, detailed list, view the full report

Market challenges
- Risks and complications associated with radiofrequency ablation
- For a full, detailed list, view the full report

Market trends
- New product launches coupled with R&D activities
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the Key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 7

FEATURED COMPANIES

  • Accuray
  • AtriCure
  • Bovie Medical
  • Halyard Health
  • Medtronic
  • PLC Medical Systems
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Five forces analysis
PART 06: Market segmentation by product
  • Global radiofrequency ablation consumables and accessories market
  • Global radiofrequency ablation systems market
  • Global radiofrequency ablation catheters market
PART 07: Market segmentation by application
  • Oncology
  • Cardiovascular
  • Pain management
  • Cosmetology
  • Gynecology
PART 08: Market segmentation by end-user
  • Hospitals
  • ASCs
  • Physicians’ offices
PART 09: Geographical segmentation
  • Radiofrequency ablation market in Americas
  • Radiofrequency ablation market in EMEA
  • Radiofrequency ablation market in APAC
PART 10: Decision framework

PART 11: Drivers and challenges
  • Market drivers
  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments
PART 12: Market trends
  • New product launches coupled with R&D activities
  • Increasing M&A
  • Emergence of robotic navigation technologies
  • Adoption of radiofrequency ablation in emerging economies
PART 13: Vendor landscape
  • Competitive scenario
PART 14: Key vendor analysis
  • AngioDynamics
  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • Stryker
  • Other prominent vendors
PART 15: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Global radiofrequency ablation market 2016-2021 ($ millions)
Exhibit 02: Five forces analysis
Exhibit 03: Global radiofrequency ablation market by product type 2016-2021 ($ millions)
Exhibit 04: Global radiofrequency ablation market by product type 2016-2021
Exhibit 05: Global radiofrequency ablation consumables and accessories market 2016-2021 ($ millions)
Exhibit 06: Global radiofrequency ablation systems market 2016-2021 ($ millions)
Exhibit 07: Common ablation catheters used during radiofrequency ablation procedure
Exhibit 08: Benefits of advanced radiofrequency ablation catheters
Exhibit 09: Global radiofrequency ablation catheters market 2016-2021 ($ millions)
Exhibit 10: Global radiofrequency ablation market by application 2016
Exhibit 11: Global radiofrequency ablation market by end-user 2016
Exhibit 12: Global radiofrequency ablation market by geography 2016-2021
Exhibit 13: Global radiofrequency ablation market by geography 2016: Lifecycle analysis
Exhibit 14: Global radiofrequency ablation market analysis by geography 2016
Exhibit 15: Global radiofrequency ablation market by geography 2016-2021 ($ millions)
Exhibit 16: Global radiofrequency ablation market by geography 2016-2021
Exhibit 17: Radiofrequency ablation market in Americas 2016-2021 ($ millions)
Exhibit 18: Radiofrequency ablation market in EMEA 2016-2021 ($ millions)
Exhibit 19: Radiofrequency ablation market in APAC 2016-2021 ($ millions)
Exhibit 20: Cancer types worldwide 2012
Exhibit 21: Impact of drivers
Exhibit 22: Product recalls in radiofrequency ablation market 2015-2016
Exhibit 23: Impact of challenges
Exhibit 24: New product launches 2015-2016
Exhibit 25: Ongoing clinical trials for radiofrequency ablation
Exhibit 26: Key M&A 2016–2017
Exhibit 27: Competitive structure of global radiofrequency ablation market
Exhibit 28: Competitive parameters in global radiofrequency ablation market
Exhibit 29: AngioDynamics: Strength assessment
Exhibit 30: AngioDynamics: Strategy assessment
Exhibit 31: AngioDynamics: Opportunity assessment
Exhibit 32: Boston Scientific: Strength assessment
Exhibit 33: Boston Scientific strategy assessment
Exhibit 34: Boston Scientific: Opportunity assessment
Exhibit 35: Medtronic: Strength assessment
Exhibit 36: Medtronic; Strategy assessment
Exhibit 37: Medtronic; Opportunity assessment
Exhibit 38: St. Jude Medical: Strength assessment
Exhibit 39: St. Jude Medical: Strategy assessment
Exhibit 40: St. Jude Medical: Opportunity assessment
Exhibit 41: Stryker: Strength assessment
Exhibit 42: Stryker: Strategy assessment
Exhibit 43: Stryker: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 7

Loading
LOADING...

4 of 7

FEATURED COMPANIES

  • Accuray
  • AtriCure
  • Bovie Medical
  • Halyard Health
  • Medtronic
  • PLC Medical Systems
  • MORE
New Report Released: – Global Radiofrequency Ablation Market 2017-2021
The author of the report recognizes the following companies as the key players in the global radiofrequency ablation market: AngioDynamics, Boston Scientific, Medtronic, St. Jude Medical, and Stryker.

Other Prominent Vendors in the market are: Accuray, Advanced Cardiac Therapeutics, APT Medical, Arthrex, AtriCure, Biosense Webster, BIOTRONIK, Bovie Medical, CardioFocus, CONMED, DVx, Hansen Medical, Halyard Health, Imricor Medical Systems, Japan Lifeline, Merit Medical Systems, MicroPort Scientific, Osypka Medical, PLC Medical Systems, RF Medical, Smith & Nephew, Spacelabs Healthcare, Spectranetics, Theraclion, and Total Vein Systems.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is new product launches coupled with R&D activities. Vendors are increasingly focusing on the development and launch of new radiofrequency ablation devices. Product launches and R&D activities will help vendors survive in the market and enhance their growth. Vendors such as Medtronic, Boston Scientific, AngioDynamics, and Merit Medical Systems are actively involved in the development of innovative devices for improving the efficacy of radiofrequency ablation procedures.”

According to the report, one of the major drivers for this market is increasing incidence of chronic disorders and growing older population. A sedentary lifestyle can negatively affect the homeostasis of the body. The dietary habits of people worldwide are changing, which make them susceptible to many disorders such as cardiovascular diseases, respiratory diseases, obesity, cancer, urology disorders, joint pain, Alzheimer's disease, and other chronic illnesses. According to the CDC data, the number of people with chronic disorders has been increasing steadily over the past two decades. So, the emphasis and focus on treatments for these diseases such as radiofrequency ablation have increased. Radiofrequency ablation devices are increasingly used to treat chest pain, joint pain, gynecological conditions, and liver and kidney problems.

Further, the report states that one of the major factors hindering the growth of this market is risks and complications associated with radiofrequency ablation. Although radiofrequency ablation is a proven MI procedure with high efficacy, certain risks and complications are associated with the procedure, which will hinder the growth prospects and will restrict their adoption among end-users. The use of energy-based ablation devices involves risks and complications not only to patients but also to physicians and operators. These devices emit hazardous radiation that can have serious, even fatal, side-effects. High-power energy devices can damage the sensitive part of the eye and the skin.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 7
  • AngioDynamics
  • Boston Scientific
  • Medtronic
  • St Jude Medical
  • Stryker
  • Accuray
  • Advanced Cardiac Therapeutics
  • APT Medical
  • Arthrex
  • AtriCure
  • Biosense Webster
  • BIOTRONIK
  • Bovie Medical
  • CardioFocus
  • CONMED
  • DVx
  • Hansen Medical
  • Halyard Health
  • Imricor Medical Systems
  • Japan Lifeline
  • Merit Medical Systems
  • MicroPort Scientific
  • Osypka Medical
  • PLC Medical Systems
  • RF Medical
  • Smith & Nephew
  • Spacelabs Healthcare
  • Spectranetics
  • Theraclion
  • Total Vein Systems
Note: Product cover images may vary from those shown
6 of 7
The methodology is available for download below.
7 of 7
Note: Product cover images may vary from those shown
Adroll
adroll